The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...

Clene is continuing to work with U.S. regulators on its plans to seek accelerated approval of CNM-Au8 for the treatment of ...

A Q&A with author and activist Mindy Uhrlaub, who shares how she is using her voice to raise awareness and support for the ...

Three years after its approval in the U.S., Radicava ORS has been prescribed to more than 13,500 ALS patients, Mitsubishi ...

Columnist Juliet Taylor used to face difficulties with stoicism, but her late husband's ALS diagnosis forced to her feel her ...

“I wanted to create a place where people can go and have all of your fellow people with ALS, along with the answers and resources readily available to be reviewed at any pace you’re comfortable,” she ...

While 55% of ALS clinicians felt very confident in managing patients’ pain and 52% said they were able to manage patients’ mood symptoms “very well,” fewer felt the same about their ability to support ...

The experimental ALS treatment usnoflast exhibited promising signs of slowed functional decline and improved breathing in a Phase 2 trial.

Managing her husband Todd's health needs means continuing to improve the processes for his ALS caregivers, writes columnist.